Journal scan

Study into smoking cessation drug finds no increased risk of serious side effects

The drug varenicline, which is used to help people quit smoking, does not have an increased risk of cardiovascular events, depression or self-harm when compared with nicotine replacement therapy (NRT), a new study has found.

This article is for subscribers only